(3R,4R,5R)-4-(Benzyloxy)-5-((R)-1,2-bis(benzyloxy)ethyl)-2-ethoxytetrahydrofuran-3-ol

Catalog No. :
ACDCOM280
CAS No. :
10310-32-4
Molecular Formula :
C29H34O6
Molecular Weight :
478.58

IUPAC Name:(3R,4R,5R)-4-(benzyloxy)-5-((R)-1,2-bis(benzyloxy)ethyl)-2-ethoxytetrahydrofuran-3-ol

(3R,4R,5R)-4-(Benzyloxy)-5-((R)-1,2-bis(benzyloxy)ethyl)-2-ethoxytetrahydrofuran-3-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$98.00Login to see priceInquiryInquiry
5g96%$253.00Login to see priceInquiryInquiry
10g96%$350.00Login to see priceInquiryInquiry
25g96%$720.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,4R,5R)-4-(Benzyloxy)-5-((R)-1,2-bis(benzyloxy)ethyl)-2-ethoxytetrahydrofuran-3-ol
IUPAC Name(3R,4R,5R)-4-(benzyloxy)-5-((R)-1,2-bis(benzyloxy)ethyl)-2-ethoxytetrahydrofuran-3-ol
MDL No.MFCD00801089
Molecular FormulaC29H34O6
Molecular Weight478.58
SMILESO[C@@H](C(O1)OCC)[C@@H](OCC2=CC=CC=C2)[C@@]1([H])[C@@H](COCC3=CC=CC=C3)OCC4=CC=CC=C4
InChI KeyULLNJSBQMBKOJH-VIVFLBMVSA-N
SynonymGlivenol;Glucofuranoside, ethyl 3,5,6-tri-O-benzyl- (7CI);Glucofuranoside, ethyl 3,5,6-tri-O-benzyl-, D- (8CI);Glyvenal;Glyvenol;Hemocuron;TBGF;Tribenzoside
CAS No.10310-32-4
PubChem CID196122

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDCOM280 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDCOM280 route product structure diagram
    ACDCOM28010310-32-4
Inquiry

2. ACDCOM280 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDCOM280 route product structure diagram
    ACDCOM28010310-32-4
Inquiry

Comments (0)